Review of imaging techniques in the diagnosis of hepatocellular carcinoma in patients who require a liver transplant

• Published in: European journal of gastroenterology & hepatology Vol. 28; no. 4; p. 412
• Main Authors: Villacastín Ruiz, Elena, Caro-Patón Gómez, Agustín, Calero Aguilar, Hermógenes, Pérez Saborido, Baltasar, García Pajares, Félix, Sánchez Antolín, Gloria, Madrigal Rubiales, Beatriz, Pacheco Sánchez, David, Pintado Garrido, Rebeca, Plaza Loma, Sara, Escudero Caro, Trinidad
• Format: Journal Article
• Language: English
• Published: England 01.04.2016
• Subjects: Adult; Aged; Carcinoma, Hepatocellular - diagnostic imaging; Carcinoma, Hepatocellular - mortality; Carcinoma, Hepatocellular - pathology; Carcinoma, Hepatocellular - surgery; Contrast Media; Female; Humans; Liver Neoplasms - diagnostic imaging; Liver Neoplasms - mortality; Liver Neoplasms - pathology; Liver Neoplasms - surgery; Liver Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Multidetector Computed Tomography; Neoplasm Staging; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Ultrasonography
• ISSN: 1473-5687
• DOI: 10.1097/MEG.0000000000000528

The aim of the study was to retrospectively compare the diagnostic performance of ultrasound (US), contrast-enhanced multidetector computed tomography (MDCT) and contrast-enhanced MRI in cirrhotic patients who were candidates for liver transplantation. A total of 273 consecutive patients with 218 hepatocellular carcinoma (HCC) nodules, who underwent imaging and subsequent transplantation, were examined. Diagnosis of HCC was based on explant correlation of the whole liver. Three different imaging data sets were evaluated: US, MDCT and MRI unenhanced and dynamic phases. Diagnostic accuracy, sensitivity, specificity, positive predictive value and negative predictive value, with corresponding 95% confidence intervals, were determined. Statistical analysis was performed for all lesions and for two lesion subgroups (≤2 and >2 cm). Preoperative tumour staging was analysed. Patient sensitivity to US, MDCT and MRI was 80.4, 81.1 and 90.5%, respectively. Specificity was 96.3, 96.2 and 82.1%. Combined US and MDCT improved sensitivity (88%) without significant loss in specificity (95.7%). Imaging tests resulted in accurate tumour staging in 83.4% of the patients. In per-nodule analysis, technique sensitivity was 55.6, 52.4 and 65.9%, respectively. Sensitivity figures improved when the nodule was larger than 2 cm. Combining imaging techniques is a good strategy for pretransplant HCC diagnosis and provides more accurate cancer staging in patients, which is necessary to decide the correct therapeutic approach.